Hormel Institute, University of Minnesota
Austin, United States
Charles Day holds a PhD in Molecular Physiology and Biophysics from Vanderbilt University and is currently a Research Fellow working jointly between the U. of Minnesota’s Hormel Institute and the Mayo Clinic. Dr. Day’s research focuses on the role of histone post-translational modifications in chromosome biology and cellular physiology, and how deregulation of histone post-translational modifications contributes to the formation and progression of brain cancer.